[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340336-105":59,"doc-detail-340336-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","molecular-landscape-of-bladder-cancer-key-genes-transcription-factors-and-drug-interactions","Molecular Landscape of Bladder Cancer - Key Genes, Transcription Factors, and Drug Interactions","","Bladder cancer is a highly malignant tumor in the urinary system with rising global impact and significant mortality. This study uses TCGA data to compare bladder cancer tissues with adjacent normal tissues and identify differentially expressed genes, then applies GO/KEGG functional enrichment, protein-protein interaction network analysis, and GSVA to reveal biological processes and pathways. Ten key genes show diagnostic value via ROC analysis, and candidate therapeutic drug interactions support biomarker and targeted therapy potential for diagnosis and prognosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-landscape-of-bladder-cancer-key-genes-transcription-factors-and-drug-interactions/340336/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-landscape-of-bladder-cancer-key-genes-transcription-factors-and-drug-interactions/340336.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study on bladder cancer?","Question",{"text":112,"@type":113},"To identify novel diagnostic markers and uncover more effective targeted therapies by mapping molecular mechanisms and key gene features in bladder cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are differentially expressed genes (DEGs) identified in this research?",{"text":117,"@type":113},"DEGs are obtained by comparing bladder cancer tissues with adjacent normal tissues using data from The Cancer Genome Atlas (TCGA).",{"name":119,"@type":110,"acceptedAnswer":120},"Which analyses are used to evaluate function, networks, and biological pathways?",{"text":121,"@type":113},"The study performs GO and KEGG enrichment, constructs a protein-protein interaction (PPI) network to find hub genes, and uses GSVA to examine involvement in biological processes and signaling pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340336,1790231060,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \n# Molecular Landscape of Bladder Cancer:Key Genes,Transcription Factors,and Drug Interactions\n\nDanishuddin1,+D,Md Azizul Haque1,+D,Shawez Khan ²D,Jong-Joo Kim1,*D and Khurshid Ahmad³,*D  \n1 Department of Biotechnology,Yeungnam University,Gyeongsan 38541,Republic of Korea;danish23@yu.ac.kr(D.);azizul@ynu.ac.kr(M.A.H.)  \n2 National Center for Cancer Immune Therapy(CCIT-DK),Department of Oncology,Copenhagen University Hospital,2730 Herlev,Denmark;shawezjmi@gmail.com3 Department of Health Informatics,College of Applied Medical Sciences,Qassim University,Buraydah 51452,Saudi Arabia  \n*  Correspondence:kimj@ynu.ac.kr (J.-J.K.);k.ahmad@qu.edu.sa(K.A.)tThese authors contributed equally to this work.  \nAbstract:Bladder cancer is among the most prevalent tumors in the urinary system and is knownfor its high malignancy.Although traditional diagnostic and treatment methods are established,recent research has focused on understanding the molecular mechanisms underlying bladder cancer.The primary objective of this study is to identify novel diagnostic markers and discover moreeffective targeted therapies for bladder cancer.This study identified differentially expressed genes(DEGs)between bladder cancer tissues and adjacent normal tissues using data from The CancerGenome Atlas(TCGA).Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses were conducted to explore the functional roles of these genes.A protein-proteininteraction(PPI)network was also constructed to identify and analyze hub genes within this network.Gene set variation analysis(GSVA)was conducted to investigate the involvement of these genes invarious biological processes and pathways.Ten key genes were found to be significantly associatedwith bladder cancer:IL6,CCNA2,CCNB1,CDK1,PLK1,TOP2A,AURKA,AURKB,FOXM1,andCALML5.GSVA analyses revealed that these genes are involved in a variety of biological processesand signaling pathways,including coagulation,UV-response-down,apoptosis,Notch signaling,and Wnt/beta-catenin signaling.The diagnostic relevance of these genes was validated throughROC curve analysis.Additionally,potential therapeutic drug interactions with these key genes wereidentified.This study provides valuable insights into key genes and their roles in bladder cancer.Theidentified genes and their interactions with therapeutic drugs could serve as potential biomarkers,presenting new opportunities for enhancing the diagnosis and prognosis of bladder cancer.  \ncheck for  \nupdates  \nCitation:Danishuddin;Haque,M.A.;Khan,S.;Kim,J.-J.;Ahmad,K.Molecular Landscape of BladderCancer:Key Genes,TranscriptionFactors,and Drug Interactions.Int.J.Mol.Sci.2024,25,10997.https://doi.org/10.3390/ijms252010997Academic Editors:Youping Deng andKurt K.Zhang  \nKeywords:bladder cancer;transcription factors;DEGs;biomarkers  \nReceived:25September 2024  \n## 1.Introduction\n\nRevised:8 October 2024  \nAccepted:11 October 2024  \nBladder cancer is the second most common type of cancer affecting the genitourinarysystem,and its prevalence is rising worldwide[1-3].The global impact of bladder cancer isbecoming increasingly significant,as demonstrated by the rising mortality rate.Therefore,it is critical to improve diagnostic and treatment methods to more effectively combatthe disease [4].In the United States alone,approximately 83,000 new cases of bladdercancer were diagnosed in 2021.Of these,around 17,000 were projected to result in death,underscoring the severity of the disease [5].The diagnosis and treatment of bladdercancer are generally classified by clinical stage into two main types:low-risk non-muscleinvasive bladder cancer(NMIBC)and the more aggressive muscle-invasive bladder cancer(MIBC)[6].  \nPublished:12October 2024  \nCopyright:◎ 2024 by the authors.Licensee MDPI,Basel,Switzerland.This article is an open access articledistributed under the terms andconditions of the Creative CommonsAttribution(CC BY)license (https://creativecommons.org/licenses/by/  \nFurthermore","cbCaie8PvCXFKoBJ","https://ap.wps.com/l/cbCaie8PvCXFKoBJ","pdf",18980476,16,"English","# 1. Introduction\n## Background and epidemiology\n## Diagnostic and treatment classification\n## Gender differences and risk distribution\n## Urothelial cell carcinoma and treatment burden\n## Advances in molecular diagnostics\n## Study rationale and molecular mechanisms","[{\"question\":\"What is the main objective of this study on bladder cancer?\",\"answer\":\"To identify novel diagnostic markers and uncover more effective targeted therapies by mapping molecular mechanisms and key gene features in bladder cancer.\"},{\"question\":\"How are differentially expressed genes (DEGs) identified in this research?\",\"answer\":\"DEGs are obtained by comparing bladder cancer tissues with adjacent normal tissues using data from The Cancer Genome Atlas (TCGA).\"},{\"question\":\"Which analyses are used to evaluate function, networks, and biological pathways?\",\"answer\":\"The study performs GO and KEGG enrichment, constructs a protein-protein interaction (PPI) network to find hub genes, and uses GSVA to examine involvement in biological processes and signaling pathways.\"}]","Molecular Landscape of Bladder Cancer - Key Genes, Transcription Factors, and Drug Interactions | PDF",1790035886,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fce6dbcaf814ff0820eaf2bcc1c0d665.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7abbe6f708b9da1656d556a7ba544fff.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3e9b21c384f1e462d1f29bade2971dd.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8cae314cf3c44885c005a0eea3c5aae.webp",980,1385]